Study guide

Ocular Emergencies, Orbital Infections, ROP, and Systemic Manifestations

EBP-EAP Examination in Paediatrics Study Guide Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Exam Structure, Governance, Ethics & Child Safeguarding

EBP-EAP Format, Delivery, Scoring, and Clinical Vignette Strategy Paediatric Ethics, Consent/Assent, Gillick Competence, and Patient Safety Child Protection, Physical/Emotional Abuse, Neglect, and Non-Accidental Injury (NAI)

2 Chapter 2: Neonatal Transition, Resuscitation & Prematurity

Delivery Room Care, Apgar Scoring, and Neonatal Resuscitation Algorithm Respiratory Distress Syndrome (RDS), Surfactant Therapy, and Bronchopulmonary Dysplasia Perinatal Asphyxia, HIE Sarnat Staging, and Therapeutic Hypothermia Protocol

3 Chapter 3: Neonatal Morbidities, Jaundice & Congenital Infections

Unconjugated vs Conjugated Hyperbilirubinemia, Phototherapy Thresholds, and Exchange Transfusion Early- vs Late-Onset Sepsis, Group B Streptococcus, and Congenital TORCH Infections NEC Diagnosis/Bell Staging, Neonatal Hypoglycaemia, and Newborn Bloodspot Screening

4 Chapter 4: Acute Paediatric Emergencies & Critical Care

EPLS/PALS Structured Approach, Types of Shock, and Weight-Based Fluid Boluses Clinical Diagnostic Criteria, Intramuscular Adrenaline Dosing, and Refractory Anaphylaxis 5-Minute Time-Critical Anticonvulsant Protocol and Status Epilepticus Care Common Toxidromes (Paracetamol, Iron, Caustics, Button Batteries) and Decontamination

5 Chapter 5: Paediatric Respiratory Medicine

Stridor Differential, Croup (Westley Score & Dexamethasone), and Epiglottitis RSV Pathogenesis, Supportive Management, Oxygen/High-Flow Criteria, and Futility of Bronchodilators/Steroids European/BTS Guidelines on Chronic Stepwise Control and Acute Severe Exacerbation Management Community-Acquired Pneumonia Etiology, Parapneumonic Effusion/Empyema, and Cystic Fibrosis Pulmonary Exacerbations

6 Chapter 6: Paediatric Cardiology

Acyanotic vs Cyanotic Congenital Heart Disease: Ductal Patency, Shunt Lesions, and Emergency Stabilization Paediatric Murmurs and Arrhythmias: Innocent vs Pathological Murmurs, SVT, and Resuscitation Protocols Acquired Heart Disease: Kawasaki Disease, Coronary Aneurysm Prevention, and Acute Rheumatic Fever

7 Chapter 7: Paediatric Gastroenterology, Hepatology & Nutrition

Dehydration Severity Assessment, Oral Rehydration Therapy (ORT), and Intravenous Fluid Protocols ESPGHAN Coeliac Diagnostic Criteria (Biopsy-Sparing Pathway) and Paediatric Crohn's/Ulcerative Colitis Breastfeeding, Formula Selection, Cow's Milk Protein Allergy (CMPA), GERD vs GOR, and Faltering Growth Prolonged Neonatal Jaundice Workup, Biliary Atresia Red Flags, and Acute Hepatitis/Liver Failure

8 Chapter 8: Paediatric Nephrology, Fluids & Electrolyte Balance

Paediatric UTI Diagnosis, Imaging Criteria (Ultrasound/DMSA/MCUG), and Vesicoureteral Reflux Minimal Change Nephrotic Syndrome (Steroid Regimen & Complications) vs Acute Post-Infectious Glomerulonephritis Paediatric AKI (pRIFLE/KDIGO), Haemolytic Uraemic Syndrome (HUS), and Hyperkalaemia/Dysnatraemia Management

9 Chapter 9: Paediatric Endocrinology & Inborn Errors of Metabolism

Paediatric DKA Protocol (ISPAD/European Fluid & Insulin Guidelines, Cerebral Oedema Prevention) and T1DM Maintenance Congenital Hypothyroidism Screening & Levothyroxine, Congenital Adrenal Hyperplasia (21-Hydroxylase Deficiency), and Adrenal Crisis Short Stature Workup, Precocious vs Delayed Puberty, and Approach to Suspected Inborn Errors of Metabolism (IEM)

10 Chapter 10: Paediatric Neurology, Neurodevelopment & Mental Health

Simple vs Complex Febrile Seizures, Childhood Epilepsy Syndromes (Absence, Infantile Spasms, Benign Rolandic), and Antiseizure Medications Red Flags for Raised Intracranial Pressure (ICP), Brain Tumours, Migraine vs Tension Headache Acute Bacterial Meningitis (LP Contraindications, Ceftriaxone, Dexamethasone) and Viral Encephalitis (Aciclovir) Developmental Milestones (Gross Motor, Fine Motor/Vision, Speech/Language, Social), Autism Spectrum, ADHD, and Cerebral Palsy

11 Chapter 11: Paediatric Haematology & Oncology

Microcytic Anaemia (Iron Deficiency vs Thalassaemia Trait/Mentzer Index), Haemolytic Anaemias (Spherocytosis, G6PD) Sickle Cell Crises (Vaso-occlusive, Acute Chest Syndrome, Stroke Prevention), Immune Thrombocytopenia (ITP), and Haemophilia A/B Acute Lymphoblastic Leukaemia (ALL), Neuroblastoma, Wilms Tumour, and Management of Febrile Neutropenia

12 Chapter 12: Paediatric Infectious Diseases, Immunology & Allergy

Common Childhood Exanthems: Clinical Morphology, Timelines, Complications, and Management Paediatric Tuberculosis, Sepsis Six in Children, and Acute Osteoarticular Infections Pediatric Allergy, Atopic Eczema, Food Hypersensitivity, and Desensitization Primary Immunodeficiencies, Warning Signs, Live Vaccine Contraindications, and European Immunisation Schedules

13 Chapter 13: Paediatric Musculoskeletal, Dermatology & Surgical Conditions

The Limping Child, Septic Arthritis vs Transient Synovitis, and Juvenile Idiopathic Arthritis Henoch-Schönlein Purpura, Kawasaki Disease vs MIS-C, Infantile Haemangiomas, and Common Pediatric Eruptions Acute Appendicitis, Intussusception, Pyloric Stenosis, Testicular Torsion, and Incarcerated Hernia

14 Chapter 14: Research Methods, Biostatistics & Evidence-Based Paediatrics

Study Designs, Causality, Bias, and Epidemiological Measures in Paediatrics Diagnostic Test Accuracy, Statistical Inference, and Hypothesis Testing Systematic Reviews, Meta-Analysis, Decision Analysis, and Paediatric Research Ethics

15 Chapter 15: Paediatric Ophthalmology & ENT Disorders

Paediatric Vision Assessment, Refractive Disorders, Strabismus, and Leukocoria Ocular Emergencies, Orbital Infections, ROP, and Systemic Manifestations Paediatric Otolaryngology: Otitis Media, Hearing Impairment, and Upper Airway Conditions

16 Chapter 16: Paediatric Sports Medicine & Musculoskeletal Health

Skeletal Maturity, Physeal Injuries, Apophysitis, and Overuse Syndromes Paediatric Sports Concussion, Second Impact Syndrome, and Return-to-Play Protocols Pre-Participation Screening, Physical Activity Guidelines, and Chronic Disease Clearance

17 Chapter 17: Adolescent Medicine & Healthcare Transition

Biopsychosocial Development, Pubertal Staging, and Adolescent Communication Adolescent Confidentiality, Risk Behaviours, Reproductive Health, and Eating Disorders Chronic Illness in Adolescence and Structured Healthcare Transition

18 Chapter 18: Paediatric Genetics, Dysmorphology & Clinical Genomics

Patterns of Inheritance, Non-Mendelian Mechanisms, and Pedigree Construction Clinical Dysmorphology, Chromosomal Aneuploidies, and Microdeletion Syndromes Genetic Testing Technologies, Prenatal Diagnosis, and Genetic Counselling Ethics

19 Chapter 19: Paediatric Mental Health, Behaviour & Community Medicine

Cognitive Development, Attachment, Screening, and Common Emotional Disorders Regulatory Disorders, Neurodevelopmental Behavioural Conditions, and Psychosomatic Illness Community Child Healthcare Structures, Disability Coordination, and Child Advocacy

Ocular Emergencies, Orbital Infections, ROP, and Systemic Manifestations

Key Takeaways Explain This Topic AI

Preseptal (periorbital) cellulitis involves only superficial soft tissues anterior to the orbital septum and presents with lid erythema and edema without visual impairment; in contrast, postseptal (orbital) cellulitis involves deep orbital structures and is distinguished by proptosis, painful ophthalmoplegia, visual compromise, and relative afferent pupillary defect (RAPD).

Postseptal orbital cellulitis is a surgical and medical emergency arising predominantly from ethmoid sinusitis (extension through the lamina papyracea); contrast-enhanced CT of the orbits and paranasal sinuses is required immediately, alongside IV broad-spectrum antibiotics covering Staphylococcus aureus, Streptococcus pneumoniae, and anaerobes, with urgent drainage for optic nerve compromise, large or unfavourably located abscesses, or failure of IV therapy; small medial collections may respond to closely monitored medical treatment.

Ophthalmia neonatorum mandates urgent etiology-specific management based on postnatal timing: Neisseria gonorrhoeae (days 2 to 5) produces hyperacute purulent discharge and threatens rapid corneal ulceration and perforation (requiring systemic ceftriaxone), while Chlamydia trachomatis (days 5 to 14) produces mucopurulent conjunctivitis requiring oral azithromycin or erythromycin to eliminate nasopharyngeal colonization and prevent chlamydial interstitial pneumonitis.

Retinopathy of prematurity (ROP) screening follows the national programme; UK 2024 criteria include gestation <31 weeks or birthweight <1501 g, with screening also considered at 31+0–31+6 weeks; peripheral retinal ischemia driven by unmonitored hyperoxia followed by relative hypoxia triggers pathological VEGF elevation, and treatment depends on zone, stage and plus disease. Type 1 ROP needs urgent specialist therapy; aggressive ROP or Zone I stage 3 plus should be treated as soon as possible within 48 hours, other treatment-requiring disease within 48–72 hours.

Paediatric systemic diseases frequently produce hallmark ocular signs: Kayser-Fleischer rings in Wilson disease, Lisch nodules in neurofibromatosis type 1, cherry-red spot at the macula in lysosomal storage diseases (Tay-Sachs, Niemann-Pick), Roth spots in infective endocarditis, and insidious, completely asymptomatic chronic anterior uveitis in ANA-positive oligoarticular juvenile idiopathic arthritis requiring scheduled slit-lamp screening to avoid blinding band keratopathy and cataracts.

Last updated: November 2026

Ocular Emergencies, Orbital Infections, ROP, and Systemic Manifestations

Paediatric ophthalmic emergencies encompass acute infections, neonatal exposures, sight-threatening vascular proliferations in preterm infants, and penetrating trauma. Because infants and young children have limited verbal capacity and rapid disease progression, the paediatrician must master rapid bedside differentiation of benign periocular complaints from acute vision- and life-threatening orbital emergencies.

Preseptal vs Postseptal (Orbital) Cellulitis

The orbital septum is a thin, fibrous sheet of connective tissue that originates from the orbital periosteum (arcus marginale) and inserts into the tarsal plates of the upper and lower eyelids. It serves as a formidable anatomical barrier separating the superficial lid structures from the deep intraorbital compartment. Infections are strictly categorized by their anatomical relationship to this septum. [Anatomy of the Orbital Compartment]

  • |
  • +------------------------+------------------------+
  • | |
  • [Anterior to Septum] [Posterior to Septum]
  • PRESEPTAL CELLULITIS - POSTSEPTAL (ORBITAL) CELLULITIS
  • Superficial facial skin infection - Deep intraorbital infection
  • Source: Insect bite, skin cut, dacryocystitis - Source: Ethmoid sinusitis (Lamina papyracea)
  • Normal vision, NO proptosis - PROPTOSIS, PAINFUL OPHTHALMOPLEGIA
  • Painless, full extraocular motility - DECREASED VISUAL ACUITY, + RAPD
  • Pupils reactive, no RAPD - Emergency contrast CT; IV broad antibiotics
  • Pathophysiology and Microbiology

Preseptal (Periorbital) Cellulitis : Involves only the subcutaneous tissues anterior to the orbital septum. It typically arises from external cutaneous breaches, such as local insect bites, facial abrasions, hordeolum (stye), or acute dacryocystitis. Causative pathogens include Staphylococcus aureus (including community-acquired MRSA), Streptococcus pyogenes (Group A Streptococcus), and Streptococcus pneumoniae .

Postseptal (Orbital) Cellulitis : Involves deep intraorbital soft tissues posterior to the orbital septum, including orbital fat, extraocular muscles, and neurovascular bundles. In over 85% to 90% of cases , orbital cellulitis develops from direct contiguous spread of acute bacterial paranasal sinusitis. The ethmoid sinus is the primary culprit because its paper-thin lateral bony wall—the lamina papyracea —is riddled with natural neurovascular perforations (anterior and posterior ethmoidal foramina) and congenital bony dehiscences, allowing facile bacterial transmigration. Valveless ophthalmic veins also permit retrograde septic thrombophlebitis. Pathogens encompass polymicrobial flora: S. aureus , S. pneumoniae , S. pyogenes , Haemophilus influenzae , and oral anaerobes ( Peptostreptococcus , Bacteroides , Fusobacterium ).

  • Chandler Classification of Orbital Infections
  • Stage I: Preseptal Cellulitis (Inflammatory edema anterior to septum)

Stage II: Orbital Cellulitis (Diffuse inflammatory infiltration within orbital adipose tissue without discrete abscess formation)

Stage III: Subperiosteal Abscess (SPA) (Pus collection between the periorbita and the bony orbital wall, classically along the medial orbital wall adjacent to the ethmoid sinus)

Stage IV: Orbital Abscess (Discrete purulent fluid collection within the intraconal or extraconal orbital soft tissue; severe proptosis and visual loss)

Stage V: Cavernous Sinus Thrombosis (Septic thrombophlebitis extending posteriorly into the intracranial cavernous sinus; characterized by bilateral proptosis, rapid chemosis, involvement of cranial nerves III, IV, V 1 , V 2 V_1, V_2 V 1 ​ , V 2 ​ , and VI, papilloedema, and fluctuating sensorium)

Clinical Differentiation and Red Flags

  • Clinical Parameter Preseptal (Periorbital) Cellulitis Postseptal (Orbital) Cellulitis
  • Eyelid Erythema & Edema Present (often marked, tense, warm) Present (violaceous, marked chemosis)
  • Proptosis (Exophthalmos) Absent (Globe is normally positioned) Present (Axial or non-axial globe displacement)
  • Extraocular Eye Movements Completely normal & pain-free Limited (ophthalmoplegia) & severely painful

Visual Acuity & Color Vision Completely preserved (normal) Decreased (Early dyschromatopsia warns of optic neuropathy)

  • Pupillary Reflexes Normal; no RAPD Relative Afferent Pupillary Defect (RAPD) indicates optic nerve compression
  • Systemic Toxicity Mild; low-grade or moderate fever High spiking fever, severe headache, lethargy
  • Primary Investigation Clinical diagnosis in mild cases Emergency contrast-enhanced CT of orbits/sinuses

Management Setting Outpatient oral antibiotics (if mild, >1 yr) Mandatory emergency admission + IV broad-spectrum antibiotics

Diagnostic Workup and Emergency Treatment Protocol

Neuroimaging : Contrast-enhanced Computed Tomography (CT) of the orbits, paranasal sinuses, and brain is the gold standard imaging modality. It must be ordered immediately whenever any postseptal clinical sign (proptosis, ophthalmoplegia, visual compromise, or inability to examine the globe due to severe lid edema) is identified. Magnetic Resonance Imaging (MRI) with MR venography is superior if intracranial extension or cavernous sinus thrombosis is suspected.

Medical Therapy : Immediate intravenous broad-spectrum antimicrobial therapy targeting S. aureus , Streptococcus species, and anaerobes: IV Ceftriaxone (or Cefotaxime) PLUS IV Vancomycin (or Flucloxacillin, depending on regional MRSA prevalence) PLUS IV Metronidazole . Adjunctive nasal decongestants and topical saline douches promote sinus drainage.

Indications for Emergency Surgical Decompression (Endoscopic sinus surgery or open orbital evacuation):

Large, non-medial or mass-effect-producing subperiosteal abscess; small medial collections may be managed with IV antibiotics and close ophthalmology/ENT monitoring if vision is preserved.

Deterioration of visual acuity, loss of red-green color discrimination, or development of an RAPD.

Persistent fever, worsening proptosis, or failure to demonstrate objective clinical improvement after 24 to 48 hours of intravenous broad-spectrum antimicrobials.

Ophthalmia Neonatorum

Ophthalmia neonatorum (neonatal conjunctivitis) is defined as any conjunctival inflammation occurring within the first 28 days of life . Infection is most commonly acquired during passage through an infected birth canal. Rapid microbiological identification is paramount because specific pathogens produce rapid corneal destruction and systemic illness. [<24 Hours Post-Natal: Chemical]

  • Silver nitrate prophylaxis (Credé)
  • Mild injection, watery discharge; self-resolving in 24-48 hours
  • |
  • v
  • [Days 2 to 5 Post-Natal: Neisseria gonorrhoeae]
  • HYPERACUTE, COPIOUS PURULENT DISCHARGE ('pus spurting from lids')
  • Severe chemosis, lid edema

- RISK OF RAPID CORNEAL PERFORATION & BLINDNESS WITHIN 24-48 HOURS!

  • Treatment: Hospitalisation + Systemic IV/IM Ceftriaxone + Frequent saline irrigation
  • |
  • v
  • [Days 5 to 14 Post-Natal: Chlamydia trachomatis]
  • Most common bacterial etiology; watery -> mucopurulent discharge
  • Pseudomembranes, palpebral follicular response absent in neonates
  • RISK OF DELAYED CHLAMYDIAL PNEUMONITIS (staccato cough at 4-12 weeks)
  • Treatment: ORAL Azithromycin or Erythromycin (Topical alone is ineffective!)
  • |
  • v
  • [Days 6 to 14+ Post-Natal: Herpes Simplex Virus (HSV-2)]
  • Periocular cutaneous vesicles, dendritic epithelial keratitis
  • Risk of fatal disseminated neonatal herpes / encephalitis
  • Treatment: Systemic IV Aciclovir + Topical Ganciclovir/Trifluridine
  • Etiological Profiles and Management Matrix

Chemical Conjunctivitis :

Onset : Within <24 hours after birth.

Pathology : Transient non-infectious chemical irritation caused by silver nitrate eye drops (Credé's prophylaxis) or rarely erythromycin ointment.

Management : Self-limiting; resolves spontaneously within 24 to 48 hours without therapeutic intervention.

Neisseria gonorrhoeae :

Onset : Classically Days 2 to 5 of life (can occur earlier if membranes ruptured prematurely).

Pathology : Gram-negative intracellular diplococci. Characterized by an explosive, hyperacute clinical presentation: intensely tense, swollen violaceous eyelids, massive chemosis, and copious, thick, creamy purulent discharge that re-accumulates immediately upon wiping. N. gonorrhoeae possesses enzymes capable of penetrating intact corneal epithelium, inducing rapid corneal ulceration, stromal melting, anterior chamber perforation, and irreversible panophthalmitis within 24 to 48 hours.

Therapy : Emergency hospital admission under contact isolation. Mandatory systemic antimicrobial therapy : single-dose IV or IM Ceftriaxone (25 to 50 mg/kg, maximum 125 mg to 250 mg; or cefotaxime if hyperbilirubinemia precludes ceftriaxone). Frequent topical ocular saline lavages (every 15 to 30 minutes initially) to clear cytolytic purulent enzymes. Treat mother and sexual partner; investigate and co-treat for Chlamydia trachomatis .

Chlamydia trachomatis (Serovars D–K):

Onset : Classically Days 5 to 14 of life.

Pathology : Obligate intracellular bacterium; the most common overall infectious cause of ophthalmia neonatorum in industrialized countries. Presents with mild-to-moderate hyperemia, eyelid edema, and mucopurulent discharge , occasionally accompanied by friable pseudo-membranes. The conjunctival lymphoid layer is immature at birth, so neonates develop a papillary rather than a classic follicular response.

Systemic Risk and Mandate for Oral Therapy : Topical antibiotics are strictly inadequate because C. trachomatis colonizes the infant's nasopharyngeal mucosa, middle ear, and respiratory tract. Infected infants can develop delayed chlamydial interstitial pneumonitis between 4 and 12 weeks of age, presenting with a pathognomonic paroxysmal 'staccato' cough, tachypnea, bilateral diffuse interstitial pulmonary infiltrates, and peripheral blood eosinophilia (without fever).

Therapy : Mandatory systemic oral therapy with oral Azithromycin (20 mg/kg/day once daily for 3 days) or oral Erythromycin (50 mg/kg/day divided in 4 doses for 14 days). Monitor infants for infantile hypertrophic pyloric stenosis following macrolide therapy. Evaluate and treat the mother and her sex partners.

Herpes Simplex Virus (HSV) :

Onset : Days 6 to 14. Unilateral or bilateral conjunctival injection, serosanguinous discharge, periocular cutaneous vesicles, and microdendritic corneal ulcers stained with fluorescein. Carries high risk of fatal disseminated multiorgan disease or encephalitis. Requires immediate IV Aciclovir (60 mg/kg/day in 3 divided doses) plus topical antiviral drops.

Retinopathy of Prematurity (ROP)

Retinopathy of prematurity is a vasoproliferative vitreoretinal disorder affecting the immature retinal vasculature of preterm infants. It represents one of the leading worldwide causes of preventable childhood blindness.

Pathophysiological Cascade: The Two-Phase Model

Normal human retinal vascularization begins at 16 weeks gestation, radiating centrifugally from the optic nerve head toward the periphery. The nasal retinal periphery is fully vascularized by 36 weeks post-menstrual age (PMA) , whereas the larger temporal periphery is completed only at full term ( 40 to 42 weeks PMA ). [Preterm Delivery with Incomplete Retinal Vascularisation]

  • |
  • v
  • [Phase 1: Hyperoxia & Vaso-Obliteration (Postnatal Weeks 0 to 4)]
  • Exposure to high ambient oxygen (room air / mechanical ventilation)
  • Sudden drop in local hypoxia triggers down-regulation of VEGF and IGF-1
  • Arrest of peripheral vessel growth; vaso-obliteration of existing capillaries
  • |
  • v
  • [Phase 2: Hypoxia & Neovascular Proliferation (Postnatal Weeks 4 to 10+)]
  • Maturing, non-vascularized peripheral retina becomes severely ischemic and hypoxic
  • Massive pathological overproduction of VEGF and IGF-1
  • Abnormal neovascular endothelial proliferation at vascular-avascular junction
  • Ridge formation, extraretinal fibrovascular proliferation, tractional retinal detachment
  • Screening Eligibility Criteria

ROP screening criteria vary by country. UK 2024 guidance recommends screening for:

Infants born at <31+0 weeks gestation; OR

Infants with birthweight <1501 g . Consider screening infants born at 31+0–31+6 weeks, especially with additional risk factors.

First screen if born <31+0 weeks : at 31+0–31+6 weeks PMA or 4 completed postnatal weeks (28–34 days), whichever is later.

First screen if eligible and born >=31+0 weeks : at 36+0–36+6 weeks PMA or 4 completed postnatal weeks (28–34 days), whichever is sooner.

Anatomical Zonation, Staging, and 'Plus Disease'

Retinopathy is categorized using the International Classification of Retinopathy of Prematurity (ICROP): [ICROP Retinal Zones]

  • +-------------------------------------------+
  • | Zone III: Residual temporal crescent |
  • | +------------------------------------+ |
  • | | Zone II: Extends to nasal ora | |
  • | | +----------------------------+ | |
  • | | | Zone I: Radius = 2x disc- | | |
  • | | | fovea distance | | |
  • | | | (Posterior Pole) | | |
  • | | +----------------------------+ | |
  • | +------------------------------------+ |
  • +-------------------------------------------+

Zones (Location) :

Zone I : Inner circular zone centered on optic disc, radius equal to twice the distance from disc center to fovea center. (Disease here carries the poorest prognosis).

Zone II : Concentric ring extending from Zone I border to the nasal ora serrata.

Zone III : Residual crescent of temporal retina outside Zone II.

Stages (Severity at Vascular-Avascular Boundary) :

Stage 1 (Demarcation Line) : A thin, flat, white line separating vascular from avascular retina.

Stage 2 (Ridge) : Demarcation line gains height, volume, and width, elevating into a prominent pink-white ridge.

Stage 3 (Extraretinal Fibrovascular Proliferation) : Neovascular tufts and fibrous tissue erupt from the ridge into the vitreous body.

Stage 4 (Partial Retinal Detachment) : Subtotal tractional detachment (4A: sparing fovea; 4B: macula detached).

Stage 5 (Total Retinal Detachment) : Funnel-shaped complete retinal detachment resulting in leukocoria and blindness.

'Plus Disease' : Marked dilatation and tortuosity of retinal arterioles and veins in the posterior pole (Zone I). Indicates severe, active hemodynamic shunting and aggressively progressing disease. Designated by a '+' symbol (e.g., Zone II, Stage 3+).

Treatment Indications

ETROP Type 1 ROP treatment criteria are listed below. UK guidance recommends treatment as soon as possible within 48 hours for aggressive ROP or Zone I stage 3 plus, and within 48–72 hours for other treatment-requiring disease:

  • Zone I, any stage with Plus disease
  • Zone I, Stage 3 without Plus disease

Zone II, Stage 2 or Stage 3 with Plus disease (ETROP). UK guidance treats Zone II stage 2 plus as borderline: treat or re-examine within one week.

Therapeutic Modalities :

Peripheral Retinal Laser Photocoagulation : Gold-standard definitive therapy. Transpupillary diode laser ablates the ischemic, avascular peripheral retina, permanently extinguishing the cellular source of pathological VEGF production.

Intravitreal Anti-VEGF Injections (Ranibizumab or Bevacizumab) : Monoclonal antibodies targeting VEGF injected directly into the mid-vitreous. Particularly advantageous for severe Zone I disease (promotes continued normal physiological vessel growth into periphery without destroying visual fields). Requires prolonged, intensive outpatient surveillance due to late disease recurrence and theoretical systemic endothelial suppression risks.

Acute Paediatric Ocular Trauma

Ocular injuries in childhood require systematic evaluation to exclude full-thickness rupture of the globe before performing any manipulative diagnostic procedures.

Corneal Abrasion

Mechanism : Tangential fingernail scratch, paper cut, or foreign object scraping corneal surface epithelium.

Presentation : Intense sharp ocular pain, blepharospasm, lacrimation, foreign body sensation, and photophobia.

Diagnosis : Instillation of sterile topical fluorescein dye followed by examination under a cobalt blue light. Epithelial defects appear as bright, glowing green abrasions against a dark blue background. Evert eyelids to search for retained subtarsal foreign bodies.

Management : Topical antibiotic ointment or drops (e.g., chloramphenicol, fusidic acid, or polymyxin B) to prevent secondary microbial keratitis; short-acting cycloplegic (cyclopentolate) to alleviate painful ciliary muscle spasm; oral analgesics. The cornea heals rapidly within 24 to 48 hours.

Caution

Never prescribe topical ophthalmic anesthetic drops (e.g., tetracaine, proxymetacaine) for home analgesia . Topical anesthetics inhibit corneal epithelial cell migration, induce profound neurotrophic corneal ulceration, and lead to rapid, irreversible corneal stromal melting and perforation .

Traumatic Hyphaema

Pathology : Collection of red blood cells in the anterior chamber following blunt ocular contusion (e.g., ball strike, elastic band snap) that tears iris or ciliary body microvessels.

Complications : Secondary rebleeding (occurring classically between Days 2 and 5 ), acute secondary glaucoma from trabecular meshwork erythrocyte clogging, and permanent corneal endothelial blood staining.

Management : Strict bed rest with head of bed elevated to 30 to 45 degrees (promotes gravitational settling of blood away from the visual axis and pupillary aperture); rigid Fox eye shield; topical cycloplegics (atropine 1%); topical corticosteroids under ophthalmology guidance. Avoid NSAIDs or aspirin. In patients with sickle cell trait/disease, hyphaema is a visual emergency because sickled erythrocytes obstruct trabecular meshwork rapidly; avoid systemic or topical carbonic anhydrase inhibitors (acetazolamide/dorzolamide) as they induce metabolic acidosis and hemoconcentration that worsens anterior chamber sickling.

Open Globe / Penetrating Eye Injury: Emergency Protocol

A full-thickness breach of the cornea, sclera, or limbus by a sharp object or high-velocity projectile represents a catastrophic surgical emergency. [Suspicion of Open Globe Injury]

  • |
  • +------------------------+------------------------+
  • | |
  • [CLINICAL RED FLAGS] [EMERGENCY PROTOCOL]
  • Peaked, 'teardrop' pupil pointing toward wound - IMMEDIATELY STOP ALL FURTHER EXAM

- Extrusion of intraocular contents (uveal tissue) - DO NOT APPLY PRESSURE OR EYE PATCH!

  • Shallow or flat anterior chamber - Place RIGID EYE SHIELD resting on bone
  • Subconjunctival 360-degree chemosis / hemorrhage - Nil by mouth (NPO) for urgent surgery
  • Visible foreign body / wound - IV antiemetics (prevent coughing/vomiting)
  • IV broad-spectrum antibiotics

Warning

In any suspected open globe injury, never apply an eye pad or patch, never measure intraocular pressure, never retract lids forcefully, and never touch protruding structures . Any extrinsic pressure on the globe will cause catastrophic extrusion of intraocular contents (vitreous, uvea, and retina). Secure a rigid eye shield (Fox shield) resting entirely on the bony orbital margins. Keep the child strictly nil-by-mouth (NPO) , administer IV analgesics and IV antiemetics (to prevent coughing, retching, or Valsalva elevation of venous pressure), administer IV broad-spectrum antibiotics, verify tetanus immunization, and transfer immediately for emergency operative closure under general anaesthesia.

Ophthalmic Signs of Paediatric Systemic Disease

The eye provides an unobstructed window into systemic vascular, metabolic, neurocutaneous, and autoimmune pathophysiology:

Systemic Disease Hallmark Ocular Sign Underlying Pathophysiological Mechanism Clinical Diagnostic Implication

Wilson Disease (Hepatolenticular degeneration) Kayser-Fleischer (KF) Rings Pathological copper deposition within Descemet's membrane of the peripheral cornea; golden-brown or greenish-bronze perilimbal ring. Present in > 95 % >95\% > 95% of patients with neurological Wilson disease and ≈ 50 % \approx 50\% ≈ 50% of pure hepatic presentations. Evaluated via slit-lamp biomicroscopy; resolves with copper chelation (penicillamine/trientine). Sunflower cataracts may co-exist.

Neurofibromatosis Type 1 (NF1) Lisch Nodules & Optic Pathway Gliomas Lisch nodules: melanocytic hamartomas of the iris stroma (smooth, yellow-brown, domed papules). Optic glioma: pilocytic astrocytoma of CN II. Lisch nodules appear after age 5 years, present in > 90 % >90\% > 90% of adults; pathognomonic diagnostic criterion for NF1. Optic gliomas require surveillance for proptosis, vision loss, and precocious puberty.

Raised Intracranial Pressure (ICP) Papilloedema Axoplasmic stasis in optic nerve axons due to elevated cerebrospinal fluid pressure in the surrounding optic sheath. Bilateral disc swelling, blurring of disc margins, cup obliteration, loss of venous pulsations, splinter flame hemorrhages. Exclude intracranial mass/hydrocephalus before lumbar puncture.

Infective Endocarditis (IE) Roth Spots Immune complex-mediated retinal vasculitis and microemboli causing capillary rupture with secondary platelet-fibrin thrombosis. Round or flame-shaped retinal hemorrhages containing a pale, white/yellowish fibrin-platelet center on fundoscopy.

Lysosomal Storage Diseases (Tay-Sachs, Niemann-Pick) Cherry-Red Spot at Macula Deposition of un-degraded lipids ( G M 2 GM_2 G M 2 ​ ganglioside in Tay-Sachs; sphingomyelin in Niemann-Pick type A) within retinal ganglion cells. Swollen, lipid-laden ganglion cells turn the macula opaque and cloudy white; the thin foveal center lacks ganglion cells, accentuating the underlying bright red choroidal vascular bed. Also seen in central retinal artery occlusion (CRAO).

Juvenile Idiopathic Arthritis (JIA) Chronic Anterior Uveitis Non-granulomatous chronic autoimmune inflammation of iris and ciliary body. Highest risk in ANA-positive, young-onset (<6 yr), oligoarticular JIA . Strikingly asymptomatic ('quiet, white eye') without pain or redness; mandates slit-lamp screening every 3 months to prevent band keratopathy, posterior synechiae, and cataracts.